CHRDL2 and hepatocellular carcinoma: Mutations in genes such as CHRDL2, STC1, CTGF, GDNF, and FGF7; which are involved in liver fibrosis and inflammation were highlighted, shedding light on their potential role in advancing MASLD towards more severe stages, including liver cirrhosis and hepatocellular carcinoma (HCC).